https://www.marketscreener.com/quote/stock/LIPIDOR-AB-66660682/news/Lipidor-AB-Announces-All-Patients-in-Lipidor-s-Phase-III-Study-with-Psoriasis-Candidate-Akp02-Have-C-41393223/?utm_source=telegram&utm_medium=social&utm_campaign=share